The FDA is notifying heart patients treating with Multaq (dronedarone) and health professionals about cases of rare, but severe liver injury resulting from taking the drug. Two of the cases have caused acute liver failure in patients leading to liver transplants.
Dronedarone is used to treat abnormal heart rhythm in patients who have had an abnormal heart rhythm during the past six months. Information about the potential risk of liver injury from dronedarone is being added to the Warnings and Precautions as well as the Adverse Reactions sections of the labels.
Patients experiencing signs and symptoms of liver injury or toxicity (anorexia, nausea, vomiting, fever, malaise, fatigue, right upper quadrant pain, jaundice, dark urine, or itching) while taking dronedarone should contact their healthcare professionals immediately.
Messa and Associates has successfully pursued litigation and obtained verdicts and settlements for victims of pharmaceutical injuries. If you or a loved one is suffering from serious injuries as a result of taking Multaq, please contact us at 1-877-MessaLaw.
No comments:
Post a Comment